Koyfin Home > Directory > Health Care > Adamas Pharma > Total Revenue

Adamas Pharma Total Revenue Chart (ADMS)

Adamas Pharma annual/quarterly Total Revenue from 2012 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Adamas Pharma Total Revenue for the quarter ending June 06, 2020 was $19m a 25.86% increase of 5m year over year
  • Adamas Pharma Total Revenue for the last 12 months ending June 06, 2020 was $64m a 18.81% increase of 12m year over year
  • Adamas Pharma Annual Total Revenue for 2019 was $55m a 37.69% increase of 21m from 2018
  • Adamas Pharma Annual Total Revenue for 2018 was $34m a 98.32% increase of 33m from 2017
  • Adamas Pharma Annual Total Revenue for 2017 was $1m a -0.18% decrease of 0m from 2016
Other Income Statement Metrics:
  • Adamas Pharma EBITDA for the quarter ending December 12, 2018 was $-25m a -22.88% increase of 6m year over year
  • Adamas Pharma Net Income for the quarter ending December 12, 2018 was $-29m a -21.08% increase of 6m year over year
View Chart On Koyfin

Quarterly ADMS Total Revenue Data

06/2020$19m
03/2020$14m
12/2019$16m
09/2019$14m
06/2019$13m
03/2019$12m
12/2018$13m
09/2018$11m
06/2018$8m
03/2018$3m

Annual ADMS Total Revenue Data

2019$55m
2018$34m
2017$1m
2016$1m
2015$2m
2014$56m
2013$71m
2012$37m
2011$2m